NOTICE REGARDING THE AVAILABILITY OF ADMINISTRATIVE SUPPLEMENTS TO SUPPORT
STUDY OF DRUG ABUSE AND CO-OCCURRING INFECTIONS INCLUDING HIV, OTHER BLOOD-
BORNE AND SEXUALLY-TRANSMITTED INFECTIONS
Release Date: March 11, 2002
NOTICE: NOT-DA-02-005
National Institute on Drug Abuse (NIDA)
(www.nida.nih.gov)
PURPOSE
The National Institute on Drug Abuse (NIDA) announces the availability of
funds to administratively supplement existing NIDA-supported research
projects (within the scope of the original grant) to study drugs of abuse and
co-occurring infections including HIV and other blood-borne and sexually
transmitted infections. Funds will be provided through administrative
supplements to take advantage of unique opportunities to support research in
all areas of drug-abuse and HIV/AIDS science. Only existing R01 and R21
grants supported by NIDA with at least one year of support remaining at the
time of the supplemental award are eligible for supplemental support under
this notice. Supplements may be requested for up to 2 years of support, but
extend no longer than the parent grant, with funding beginning no later than
September 30, 2002. For more information refer to
http://www.drugabuse.gov/Funding/AIDSSupplement.html.
INQUIRIES
Inquiries concerning this notice are strongly encouraged. The opportunity to
clarify any issue or questions from potential applicants is welcome.
o Direct any questions about this notice to:
Sander Genser, M.D., M.P.H., or Jag H. Khalsa, Ph.D.
Center on AIDS and Other Medical Consequences of Drug Abuse
National Institute on Drug Abuse
6001 Executive Boulevard, Room 5198, MSC 9593
Bethesda, MD 20892-9581
Telephone: (301) 443-1801
E-mail: sg73f@nih.gov or jk98p@nih.gov
Return to NIH Guide Main Index
|
Office of Extramural Research (OER) |
|
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
|
Department of Health and Human Services (HHS) |
|
||||
|
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |
||||||||||